促炎细胞因子
生物
免疫学
CXCL2型
移植
趋化因子
信号转导
细胞因子
细胞生物学
移植排斥反应
CXCL10型
器官移植
炎症
癌症研究
免疫系统
医学
趋化因子受体
内科学
作者
Chen Liu,Juntao Chen,Baoqing Liu,Shunzong Yuan,Dawei Shou,Liang Wen,Xiaoying Wu,Weihua Gong
出处
期刊:European Cytokine Network
[John Libbey Eurotext]
日期:2018-06-01
卷期号:29 (2): 48-51
被引量:23
标识
DOI:10.1684/ecn.2018.0410
摘要
Since pro-inflammatory cytokine IL-18 and its receptor (IL-18R) are closely involved in regulating both adaptive and innate immune responses, it is conceivable that they might play an important role in organ transplantation.IL-18 can stimulate lymphocytes to produce the IFN-␥ and regulate macrophage activity, thereby increasing the expression of proinflammatory cytokines including IL-1, IL-6, CCL4 (macrophage inflammatory protein-1 ), CXCL2 (macrophage inflammatory protein-2), and CCL2 (monocyte chemotactic protein-1).Nevertheless, the IL-18 signaling pathway and its underlying mechanisms remain obscure in transplant biology.This review is to summarize recent advances in our knowledge about the IL-18 signaling pathway and to analyze their functions in transplant-related biology.It was found that IL-18/IL-18R signaling pathway contributed to vascular transplantation, ischemmia/reperfusion, acute kidney injury, and acute rejection of kidney/liver/heart transplantation.IL-18 was a potential CYP3A expression modulator and was capable of affecting tacrolimus pharmacokinetics.Neutralizing IL-18 by its inhibitor IL-18 binding protein could efficiently suppress the production of injury-associated cytokines such as IL-6, TNF-␣, IFN-␥, CXCL10 (IFN-␥-inducible protein10), and CX 3 CL1 (fractalkine) and improve allograft function.Blockade of IL-18 signaling could regulate cardiomyocyte apoptosis and inhibit Th17 cells differentiation.Alteration of IL-18 levels was suggested as a biomarker for predicting ongoing allograft outcome.All these activities could deepen our understanding of immunobiological role of IL-18 and its receptor in the field of organ transplantation.Intervention of IL-18 signaling pathway might be utilized as a therapeutic strategy in clinic.
科研通智能强力驱动
Strongly Powered by AbleSci AI